These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9050037)

  • 21. [Amyloidosis and renal failure].
    Musini S; Savazzi GM
    Recenti Prog Med; 1999 Oct; 90(10):530-5. PubMed ID: 10592739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of renal amyloidosis].
    MIGUERES J
    Alger Medicale; 1960 Dec; 64():1065-7. PubMed ID: 13770465
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy.
    Moroni G; Banfi G; Montoli A; Bucci A; Bertani T; Ravelli M; Pozzi C; Leonelli M; Lupo A; Volpi A
    Clin Nephrol; 1992 Aug; 38(2):81-5. PubMed ID: 1516284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of renal transplant in hereditary gelsolin amyloidosis.
    Shoja MM; Ardalan MR; Tubbs RS; Kiuru-Enari S
    Am J Med Sci; 2009 May; 337(5):370-2. PubMed ID: 19440061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical aspects of renal amyloidosis].
    Mukhin NA
    Klin Med (Mosk); 1983 Oct; 61(10):12-7. PubMed ID: 6645318
    [No Abstract]   [Full Text] [Related]  

  • 26. Renal amyloidosis followed more than 5 years: report of 12 cases.
    Kaaroud H; Boubaker K; Béji S; Abderrahim E; Moussa FB; Turki S; Goucha R; Hedri H; El Younsi F; Kheder A; Maiz HB
    Transplant Proc; 2004; 36(6):1796-8. PubMed ID: 15350480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous ambulatory peritoneal dialysis as a promising therapy for light chain amyloidosis with congestive heart failure.
    Núñez J; Teruel A; Quiñones-Torrelo C; García-Blas S; Carratalá A; Miñana G; Santas E; Torregrosa I; Solano C; González M
    Int J Cardiol; 2016 Nov; 223():807-809. PubMed ID: 27575781
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and biochemical outcome of renal amyloidosis.
    Odabas AR; Cetinkaya R; Selcuk Y; Erman Z; Bilen H
    Int J Clin Pract; 2002 Jun; 56(5):342-4. PubMed ID: 12137441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
    Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
    Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy options in systemic AL-amyloidosis with renal involvement].
    Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nephrologic aspects of amyloidosis].
    Maduell F; Diez J; Idoate M; Pardo-Mindán FJ; Purroy A
    Rev Med Univ Navarra; 1988; 32(3):153-7. PubMed ID: 3070686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Perspectives on remission in renal amyloidosis].
    Dyk T
    Pol Tyg Lek; 1965 Dec; 20(49):1867-9. PubMed ID: 5324247
    [No Abstract]   [Full Text] [Related]  

  • 33. [Causes and treatment of systemic amyloidosis].
    Blank N; Hegenbart U; Schönland S
    Z Rheumatol; 2016 Mar; 75(2):141-50. PubMed ID: 26768274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical Characteristics and Therapeutic Efficacy of Multiple Myeloma Combined with Renal Amyloidosis].
    Wen HY; Gan SL; Ma J; Xie XS; Liu YF; Jiang ZX; Sun L; Liu LX; Wang F; Meng XL; Chen SQ; Chen YD; Wan DM; Sun H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):474-7. PubMed ID: 27151013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal amyloidosis.
    Lachmann HJ; Gillmore JD
    Br J Hosp Med (Lond); 2010 Feb; 71(2):83-6. PubMed ID: 20220695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal amyloidosis.
    Jazbeh S; Said A; Haddad RY; Hamad A; Lerma EV
    Dis Mon; 2014 Oct; 60(10):489-93. PubMed ID: 25280992
    [No Abstract]   [Full Text] [Related]  

  • 37. Perimembranous-type renal amyloidosis: a peculiar form of AL amyloidosis.
    Shiiki H; Shimokama T; Yoshikawa Y; Onoyama K; Morimatsu M; Watanabe T
    Nephron; 1989; 53(1):27-32. PubMed ID: 2779700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
    Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
    Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal amyloidosis--a clinicopathologic study.
    Shah VB; Phatak AM; Shah BS; Kandalkar BM; Haldankar AR; Ranganathan S
    Indian J Pathol Microbiol; 1996 Jul; 39(3):179-85. PubMed ID: 8972145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
    Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
    Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.